首页
订购/客服:400-666-5481

(3,3-二氟吡咯烷-1-基)[(2S,4S)-4-[4-(嘧啶-2-基)哌嗪-1-基]吡咯烷-2-基]甲酮

    
≥98%

(3,3-Difluoropyrrolidin-1-yl)[(2S,4S)-4-[4-(pyrimidin-2-yl)piperazin-1-yl]pyrrolidin-2-yl]methanone

源叶(MedMol)
V40108 一键复制产品信息
869490-23-3
C17H24F2N6O
366.41
(3,3-二氟吡咯烷-1-基)[(2S,4S)-4-[4-(嘧啶-2-基)哌嗪-1-基]吡咯烷-2-基]甲酮;(3,3-Difluoropyrrolidin-1-yl)[(2S,4S)-4-[4-(pyrimidin-2-yl)piperazin-1-yl]pyrrolidin-2-yl]methanone;Gosogliptin
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
V40108-1mg
≥98%

¥1050.00

货期:3-5天 - - - -
V40108-5mg
≥98%

¥2640.00

货期:3-5天 - - - -
V40108-10mg
≥98%

¥4040.00

货期:3-5天 - - - -
V40108-25mg
≥98%

¥7260.00

货期:3-5天 - - - -
V40108-50mg
≥98%

¥9790.00

货期:3-5天 - - - -
V40108-100mg
≥98%

¥13200.00

货期:3-5天 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
体内研究: The objectives of the present study are to characterize the metabolism, pharmacokinetics, and excretion of [14C] Gosogliptin in Sprague-Dawley (SD) rats, beagle dogs, and humans. A single dose of [14C] Gosogliptin is administered orally to intact SD rats (5 mg/kg), beagle dogs (5 mg/kg), and humans (20 mg). After a single oral dose of [14C] Gosogliptin to SD rats, an overall mean of 97.1% of the administered radioactivity is recovered in the urine, feces, and cage wash over a period of 168 h postdose. The mean cumulative dose recovered in feces is 66.0%. The mean cumulative excretion in the urine is 30.8%. Approximately 95% of the excreted radioactivity recovery occurred in the first 48 h. Mean total recoveries of dosed radioactivity from bile duct-cannulated rats are 29.5% in urine and 62.0% in bile. No gender-related differences are observed in the excretion pattern of radioactivity.
保存条件: -20℃
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 2.729 ml 13.646 ml 27.292 ml
5 mM 0.546 ml 2.729 ml 5.458 ml
10 mM 0.273 ml 1.365 ml 2.729 ml
50 mM 0.055 ml 0.273 ml 0.546 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×